Gerresheimer stock at EUR 32.10, up 0.56% premarket
Published on 11/12/2026 at 08:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat investors should watch next
- Gerresheimer reported revenue growth and stable adjusted EBITDA for the third quarter on October 30, 2026.
- The investor calendar lists the Q3 quarterly release for December 2026.
- The Berenberg European Conference is scheduled for December 2, 2026, in London.
Gerresheimer stock traded at 32.10 euros on Lang & Schwarz at 08:03 CET on Thursday, November 12, 2026, 0.56 percent above the Xetra close of Wednesday, November 11, at EUR 31.92.
Premarket signal meets upcoming milestones
The move places the stock above the previous Xetra session's close before trading begins in Frankfurt. The premarket indication gives investors an early measure of demand, while the next company-specific catalysts remain on the corporate calendar.
Gerresheimer's investor relations page lists the company's third-quarter 2026 corporate update from October 30, which highlighted revenue growth and stable adjusted EBITDA. The same page lists a Q3 quarterly release for December 2026 and the Berenberg European Conference for December 2, 2026. Those dates provide the next scheduled points for investors to assess operating momentum and management commentary.
The company focuses on products for pharmaceutical, biopharmaceutical and veterinary applications, making revenue development and profitability in its operating businesses central to the share-price outlook. Investors will also weigh whether the stronger trading indication is sustained once regular Xetra trading starts.
German equities are tracked in the DAX.
